Aimei Health Technology Co., Ltd. financial data

Symbol
AFJK, AFJKR, AFJKU on Nasdaq
Location
10 East 53 Rd Street, Suite 3001, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.44 % -99.5%
Debt-to-equity -101 % +42.8%
Return On Equity -55.4 %
Return On Assets 2.71 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.12M shares
Common Stock, Shares, Outstanding 2.13M shares 0%
Entity Public Float 71.4M USD
Common Stock, Value, Issued 213 USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -987K USD +34.9%
Nonoperating Income (Expense) 2.39M USD -48.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 1.41M USD -52.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 24.9K USD -79.9%
Assets 45.5M USD -37.5%
Accrued Liabilities, Current 293K USD +106%
Liabilities, Current 2.77M USD +1102%
Liabilities 3.46M USD +276%
Retained Earnings (Accumulated Deficit) -3.44M USD -332%
Stockholders' Equity Attributable to Parent -3.44M USD -332%
Liabilities and Equity 45.5M USD -37.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -224K USD -34.2%
Net Cash Provided by (Used in) Financing Activities -30.6M USD
Net Cash Provided by (Used in) Investing Activities 30.8M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 2.13M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.9K USD +87.5%
Unrecognized Tax Benefits 0 USD